Speaker illustration

Doctor Attila Borbely

University of Debrecen, Debrecen (Hungary)

Member of:

European Society of Cardiology
Heart Failure Association

Dr. Borbély graduated in 2002 from the University of Debrecen, Hungary, receiving his PhD in 2005. He became a cardiologist in 2010, an invasive cardiologist in 2015, and a heart failure (HF) specialist in 2021, endorsed by the British Society for Heart Failure. He visited the Department of Physiology in Amsterdam from 2003 to 2004 with a Marie Curie Fellowship and received a Basic Research Fellowship grant from the HFA of the ESC between 2008 and 2010, focusing on HFpEF cellular pathophysiology. Currently, Dr. Borbély is a staff cardiologist at the Institute of Cardiology, Debrecen. His research focuses on HF pathophysiology, inotropes, inodilators, and myosin activators/inhibitors' effects at the cellular level. He established the Heart Failure Outpatient Clinic in Debrecen and coordinates HF patient evaluation for heart transplantation/LVAD regionally. He is currently the president of the Working Group on Heart Failure and Cardiomyopathies of the Hungarian Society of Cardiology.

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice

Event: ESC Congress 2018

Topic: Treatment

Session type: Practical Tutorials

Thumbnail

Inotropes or inodilators in HFrEF: what to use, on whom, when and how? - Therapeutic options and clinical practice

Event: ESC Congress 2018

Topic: Treatment

Session type: Practical Tutorials

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb